CN110591926A - 一种冠突散囊菌生产发酵方法、菌粉及药物 - Google Patents
一种冠突散囊菌生产发酵方法、菌粉及药物 Download PDFInfo
- Publication number
- CN110591926A CN110591926A CN201910844418.3A CN201910844418A CN110591926A CN 110591926 A CN110591926 A CN 110591926A CN 201910844418 A CN201910844418 A CN 201910844418A CN 110591926 A CN110591926 A CN 110591926A
- Authority
- CN
- China
- Prior art keywords
- filtrate
- eurotium cristatum
- tea
- powder
- fermentation method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/08—Oxidation; Fermentation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
Abstract
本发明涉及生物化工领域,具体为一种冠突散囊菌生产发酵方法、菌粉及药物;将茶叶和活性添加成分按比例混合得到原料,处理原料得到前滤液和第一滤渣,处理第一滤渣得到发酵茶渣,处理发酵茶渣得到后滤液,混合部分前滤液和后滤液得到冠突散囊孢子悬浮液,将所述孢子悬液进行离心处理,以便获得菌泥;向所述菌泥中加入冻干保护剂,进行冻干处理,以便获得冠突散囊菌菌粉;药物用于增强免疫力,预防或治疗糖尿病、高血脂或肿瘤等疾病;本发明开发了一种以茯茶为原料、具有调节血脂、改善血液和增强免疫力的提取物及其相关产品的用途,为推广利用和深加工茯茶提供依据,并提供了新的应用方向。
Description
技术领域
本发明涉及生物化工领域,具体为一种冠突散囊菌生产发酵方法、菌粉及药物。
背景技术
茯茶,是以黑毛茶或粗老绿茶为原料,经过再加工的后发酵茶,属于我国六大基本茶类中黑茶的一种,也是全发酵茶。茯茶历史悠久,因其是在夏季伏天加工制作,其香气和作用又类似茯苓,故称茯茶。茯茶的主要形式为紧压茶,即在制作过程中为了便于运输和保藏,生产者将其紧压加工成砖的样式,使其外形看似像砖块,故又名“茯砖茶”。
现代药理研究表明,茯茶具有显著的促消化、降血脂、养胃瘦身、调节糖代谢、抑制肿瘤细胞和增强免疫力等健康功效。长期饮用茯茶,能够促进人体新陈代谢、提高免疫力、增强体质、延缓衰老,具有明显的药理保健和病理预防作用。
研究表明,茯茶的药理活性是茶叶本身活性成分和发酵过程中自然形成的一种优势菌-冠突散囊菌(Eurotium cristatum)共同作用的结果。冠突散囊菌对茯茶的品质和药理功效的发挥起了重要作用。冠突散囊菌在茯茶中称作“金花菌”,属于散囊菌目发菌科散囊菌属的一种灰绿色曲霉真菌,适合在土壤、茯砖茶、冬虫夏草、中药片和木屑中生长。冠突散囊菌由子囊果和菌丝组成。冠突散囊菌能生产丰富的天然活性成分,从而赋予了茯砖茶特有的色、香、味,也是茯茶促消化、降脂减肥、抑制肿瘤细胞和治疗心血管疾病等保健功效的物质基础。
发明内容
为了解决以上的技术效果,本发明提供一种冠突散囊菌菌粉、制备方法及应用;
本发明是这样实现的:
一种冠突散囊菌菌粉制备方法,将茶叶和活性添加成分按比例混合得到原料,处理原料得到前滤液和第一滤渣,处理第一滤渣得到发酵茶渣,处理发酵茶渣得到后滤液,混合部分前滤液和后滤液得到冠突散囊孢子悬浮液,将所述孢子悬液进行离心处理,以便获得菌泥;向所述菌泥中加入冻干保护剂,进行冻干处理,以便获得冠突散囊菌菌粉。
进一步的,前滤液的处理方法包括:将所述茶叶和所述活性添加成分按照重量比100∶4-8∶0.5-3混合后熬煮1~2h。
进一步的,茶叶包括重量比为4~20:1的黑茶和茯苓茶的混合物,所述活性添加成分包括枸杞或红枣或西洋参中的一种或多种混合物。
进一步的,发酵茶渣的制备方法包括:在所述第一滤渣中加入食醋,调节pH至5.5~6.5后晾至至湿度为60-75%,放入至容器密封,在15-20℃下储藏15-45天。
进一步的,后滤液的制备方法包括:将所述发酵茶渣加水熬煮 30~60min后过滤收集滤液,为后滤液。
进一步的,加入所述水与所述发酵茶渣的质量比为5~10:1。
进一步的,冠突散囊菌菌粉是通过权利要求上述的方法制备获得的。
进一步的,所述药物、食品用于增强免疫力,预防或治疗糖尿病、高血脂或肿瘤等疾病。
一种药物,包含权利要求上述的冠突散囊菌菌粉;以及药学上可接受的赋形剂。
进一步的,药物用于增强免疫力,预防或治疗糖尿病、高血脂或肿瘤等疾病。
上述方案的有益效果:
本发明开发了一种以茯茶为原料、具有调节血脂、改善血液和增强免疫力的提取物及其相关产品的用途,为推广利用和深加工茯茶提供依据,并提供了新的应用方向。
具体实施方式
实施例1
步骤1,按照按照重量份称取20份黑茶、60份文冠果树叶和5 份茯茶;
步骤2,将三种原料放入水中熬煮1小时,过滤收集滤液,称为前滤液,再用食醋调节前滤液pH到5.5~6.5后,冷藏备用;
步骤3,在步骤2所得茶渣中加入食醋,调节pH到5.5~6.5,再将茶渣晾至湿度为60%,再用三层医用纱布包裹,放入搪瓷器皿内,密封,15℃下储藏15天,得发酵茶渣;
步骤4,将步骤3所得发酵茶渣加纯净水熬煮30分钟,然后过滤收集滤液,称为后滤液;
步骤5,将后滤液与前滤液混合,即制成冠突散囊孢子悬浮液。
步骤6,将步骤2制得的剩余前滤液冠突散囊孢子悬浮液按照与碳源营养物质按体积质量比为100∶4的比例混合配制,配置的溶液 pH为5.0-5.5,然后在温度条件为115℃,压力在0.12MPa条件下,持续灭菌20min即得无菌培养液。
步骤7,将步骤5制得的冠突散囊孢子悬浮液按照8%的接种量接入由步骤二制得的无菌培养液中,设置发酵参数分别为:转速 500r/min,pH值为5.5,溶氧40%,温度30℃,培养168h,当发酵液颜色呈红艳透明且菌丝量不再增加时停止发酵。
步骤8,收集并浓缩步骤7所得的发酵液,去除水分,得到冠突散囊菌。
实施例2
步骤1,按照按照重量份称取40份黑茶、40份文冠果树叶和2 份茯茶;
步骤2,将三种原料放入水中熬煮1.5小时,过滤收集滤液,称为前滤液,再用食醋调节前滤液pH到5.5~6.5后,冷藏备用;
步骤3,在步骤2所得茶渣中加入食醋,调节pH到5.5~6.5,再将茶渣晾至湿度为70%,再用三层医用纱布包裹,放入搪瓷器皿内,密封,117℃下储藏30天,得发酵茶渣;
步骤4,将步骤3所得发酵茶渣加纯净水熬煮45分钟,然后过滤收集滤液,称为后滤液;
步骤5,将后滤液与前滤液混合,即制成冠突散囊孢子悬浮液。
步骤6,将步骤2制得的剩余前滤液冠突散囊孢子悬浮液按照与碳源营养物质按体积质量比为100∶4的比例混合配制,配置的溶液 pH为5.0-5.5,然后在温度条件为115℃,压力在0.12MPa条件下,持续灭菌20min即得无菌培养液。
步骤7,将步骤5制得的冠突散囊孢子悬浮液按照8%的接种量接入由步骤二制得的无菌培养液中,设置发酵参数分别为:转速 500r/min,pH值为5.5,溶氧30%,温度30℃,培养168h,当发酵液颜色呈红艳透明且菌丝量不再增加时停止发酵。
步骤8,收集并浓缩步骤7所得的发酵液,去除水分,得到冠突散囊菌。
实施例3
步骤1,按照按照重量份称取35份黑茶、45份文冠果树叶和4 份茯茶;
步骤2,将三种原料放入水中熬煮1~2小时,过滤收集滤液,称为前滤液,再用食醋调节前滤液pH到5.5~6.5后,冷藏备用;
步骤3,在步骤2所得茶渣中加入食醋,调节pH到5.5~6.5,再将茶渣晾至湿度为60-75%,再用三层医用纱布包裹,放入搪瓷器皿内,密封,15-20℃下储藏15-45天,得发酵茶渣;
步骤4,将步骤3所得发酵茶渣加纯净水熬煮30~60分钟,然后过滤收集滤液,称为后滤液;
步骤5,将后滤液与前滤液混合,即制成冠突散囊孢子悬浮液。
步骤6,将步骤2制得的剩余前滤液冠突散囊孢子悬浮液按照与碳源营养物质按体积质量比为100∶8的比例混合配制,配置的溶液 pH为5.0-5.5,然后在温度条件为125℃,压力在0.15MPa条件下,持续灭菌30min即得无菌培养液。
步骤7,将步骤5制得的冠突散囊孢子悬浮液按照8%的接种量接入由步骤二制得的无菌培养液中,设置发酵参数分别为:转速 300r/min,pH值为5.5,溶氧40%,温度30℃,培养120h,当发酵液颜色呈红艳透明且菌丝量不再增加时停止发酵。
步骤8,收集并浓缩步骤7所得的发酵液,去除水分,得到冠突散囊菌。
实施例4
基于实施例1~3任意实施例提供的冠突散囊菌在药物和食品中能够用于增强免疫力,预防或治疗糖尿病、高血脂或肿瘤等疾病。
实施例5
一种药物,基于实施例1~3任意实施例提供的冠突散囊菌,形式为药学上可接受的赋形剂。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种冠突散囊菌菌粉制备方法,其特征在于,将茶叶和活性添加成分按比例混合得到原料,处理原料得到前滤液和第一滤渣,处理第一滤渣得到发酵茶渣,处理发酵茶渣得到后滤液,混合部分前滤液和后滤液得到冠突散囊孢子悬浮液,将所述孢子悬液进行离心处理,以便获得菌泥;向所述菌泥中加入冻干保护剂,进行冻干处理,以便获得冠突散囊菌菌粉。
2.根据权利要求1所述的冠突散囊菌生产发酵方法,其特征在于,所述前滤液的处理方法包括:将所述茶叶和所述活性添加成分按照重量比100∶4-8∶0.5-3混合后熬煮1~2h。
3.根据权利要求2所述的冠突散囊菌生产发酵方法,其特征在于,所述茶叶包括重量比为4~20:1的黑茶和茯苓茶的混合物,所述活性添加成分包括枸杞或红枣或西洋参中的一种或多种混合物。
4.根据权利要求1所述的冠突散囊菌生产发酵方法,其特征在于,所述发酵茶渣的制备方法包括:在所述第一滤渣中加入食醋,调节pH至5.5~6.5后晾至至湿度为60-75%,放入至容器密封,在15-20℃下储藏15-45天。
5.根据权利要求1所述的冠突散囊菌生产发酵方法,其特征在于,所述后滤液的制备方法包括:将所述发酵茶渣加水熬煮30~60min后过滤收集滤液,为后滤液。
6.根据权利要求5所述的冠突散囊菌生产发酵方法,其特征在于,加入所述水与所述发酵茶渣的质量比为5~10:1。
7.一种冠突散囊菌菌粉,其特征在于,所述冠突散囊菌菌粉是通过权利要求1~6任一项所述的方法制备获得的。
8.根据利要求7所述的冠突散囊菌菌粉在制备药物、食品中的用途,其特征在于,所述药物、食品用于增强免疫力,预防或治疗糖尿病、高血脂或肿瘤等疾病。
9.一种药物,其特征在于,包含权利要求6所述的冠突散囊菌菌粉;以及药学上可接受的赋形剂。
10.根据权利要求9所述的药物,其特征在于,所述药物用于增强免疫力,预防或治疗糖尿病、高血脂或肿瘤等疾病。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910844418.3A CN110591926A (zh) | 2019-09-06 | 2019-09-06 | 一种冠突散囊菌生产发酵方法、菌粉及药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910844418.3A CN110591926A (zh) | 2019-09-06 | 2019-09-06 | 一种冠突散囊菌生产发酵方法、菌粉及药物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110591926A true CN110591926A (zh) | 2019-12-20 |
Family
ID=68858330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910844418.3A Pending CN110591926A (zh) | 2019-09-06 | 2019-09-06 | 一种冠突散囊菌生产发酵方法、菌粉及药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110591926A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111235038A (zh) * | 2020-02-28 | 2020-06-05 | 深圳市清生元生物技术股份有限公司 | 一种冠突散囊菌株及其发酵液提取物的制备方法 |
CN111603492A (zh) * | 2020-06-28 | 2020-09-01 | 陕西巨子生物技术有限公司 | 一种具有调节血糖及血脂功能的组合物及其用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101456509B1 (ko) * | 2013-02-18 | 2014-10-31 | 재단법인 하동녹차연구소 | 중국 복전차로부터 분리된 금화균인 유로티움 크리스타텀 균주 |
CN104739888A (zh) * | 2013-12-31 | 2015-07-01 | 深圳华大基因科技有限公司 | 冠突散囊菌菌粉及其制备方法和应用 |
CN105831309A (zh) * | 2016-05-16 | 2016-08-10 | 陕西文冠果实业集团有限公司 | 一种文冠果茯茶的制备方法 |
CN106011047A (zh) * | 2016-05-16 | 2016-10-12 | 陕西文冠果实业集团有限公司 | 用于文冠果茯茶的冠突散囊菌孢子悬浮液的制备方法 |
CN109182140A (zh) * | 2018-09-21 | 2019-01-11 | 张峰 | 一种冠突散囊菌孢子悬浮液的制备方法 |
-
2019
- 2019-09-06 CN CN201910844418.3A patent/CN110591926A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101456509B1 (ko) * | 2013-02-18 | 2014-10-31 | 재단법인 하동녹차연구소 | 중국 복전차로부터 분리된 금화균인 유로티움 크리스타텀 균주 |
CN104739888A (zh) * | 2013-12-31 | 2015-07-01 | 深圳华大基因科技有限公司 | 冠突散囊菌菌粉及其制备方法和应用 |
CN105831309A (zh) * | 2016-05-16 | 2016-08-10 | 陕西文冠果实业集团有限公司 | 一种文冠果茯茶的制备方法 |
CN106011047A (zh) * | 2016-05-16 | 2016-10-12 | 陕西文冠果实业集团有限公司 | 用于文冠果茯茶的冠突散囊菌孢子悬浮液的制备方法 |
CN109182140A (zh) * | 2018-09-21 | 2019-01-11 | 张峰 | 一种冠突散囊菌孢子悬浮液的制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111235038A (zh) * | 2020-02-28 | 2020-06-05 | 深圳市清生元生物技术股份有限公司 | 一种冠突散囊菌株及其发酵液提取物的制备方法 |
CN111603492A (zh) * | 2020-06-28 | 2020-09-01 | 陕西巨子生物技术有限公司 | 一种具有调节血糖及血脂功能的组合物及其用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103535469A (zh) | 一种保健养生六堡茶及其制备方法 | |
CN103013767B (zh) | 南瓜起泡酒的制作方法 | |
CN104431090A (zh) | 一种红茶菌的生产方法及其产品 | |
CN104382164A (zh) | 一种灵芝红茶菌 | |
CN110591926A (zh) | 一种冠突散囊菌生产发酵方法、菌粉及药物 | |
CN112094753A (zh) | 太岁培养营养液及运用发酵工艺培养肉灵芝的方法 | |
CN103666905A (zh) | 黄芪保健酒 | |
CN102742690B (zh) | 一种保健养生功能茶叶及其制备方法 | |
CN112877173B (zh) | 一种黑茶复合茯苓液态发酵菌丝保健醋及其制备方法 | |
CN102994309A (zh) | 银杏高粱酒及银杏高粱健身酒 | |
CN111955721A (zh) | 一种天麻食用菌风味多酚液体植物酵素配方及其制备方法 | |
CN110923101A (zh) | 一种六味地黄保健酒的加工方法 | |
CN1036470C (zh) | 食用菌与中草药混合发酵酿造的产品及其方法 | |
CN103525684A (zh) | 灵芝深层发酵液制备灵芝醋的方法 | |
CN110591925A (zh) | 一种冠突散囊菌生产发酵方法 | |
CN106753970A (zh) | 茯苓养生果酒及其制备方法 | |
CN113278487A (zh) | 一种制备杞菊地黄保健酒的方法 | |
CN103349266B (zh) | 一种串叶松香草酱油 | |
CN106754116A (zh) | 一种北冬虫夏草保健酒 | |
KR101385234B1 (ko) | 간기능을 위한 오가피추출물을 천연배지로 하여 획득한 오가피-버섯 발효물과, 이의 제조방법 | |
CN106343306A (zh) | 保健口服液的制备方法 | |
CN112220041A (zh) | 一种霍山石斛酵素及其制备方法 | |
CN113826885B (zh) | 高产sod青梅酵素的制备方法及应用 | |
CN105255651B (zh) | 一种小球藻多肽酒及其制备方法 | |
CN1350860A (zh) | 糖尿病人用的保健口服液生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191220 |
|
RJ01 | Rejection of invention patent application after publication |